Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome
    PDF
    Cite
    Share
    Request
    Review
    P: 117-122
    June 2019

    Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome

    J Turk Ger Gynecol Assoc 2019;20(2):117-122
    1. Department of Urology, Koç University School of Medicine, İstanbul, Turkey
    2. Department of Urology, Koç University School of Medicine, İstanbul, Turkey
    3. Department of Urology, Marmara University School of Medicine, İstanbul, Turkey
    4. Department of Urology, Marmara University School of Medicine, İstanbul, Turkey
    No information available.
    No information available
    Received Date: 30.07.2018
    Accepted Date: 19.11.2018
    Publish Date: 28.05.2019
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Herein, we aimed to review, report, and discuss the role of cystoscopy and clinical phenotyping in interstitial cystitis/bladder pain syndrome (IC/BPS). For this purpose; a comprehensive nonsystematic review of the relevant literature was conducted. We reviewed articles published in English and indexed in the PubMed, Embase, and Google Scholar databases. Original manuscripts, review articles, case series, and case reports were taken into consideration. Data regarding the indications for, technique, and possible findings of cystoscopy with hydrodistension (HD) and biopsy, as well as clinical implications of cystoscopic information and the concept and use of clinical phenotyping within the context of IC/ BPS were extracted and discussed. IC/BPS is diagnosed based on symptomatic assessment and exclusion of confusable diseases. There is no universal agreement upon the evaluation and diagnostic algorithm of IC/BPS. The majority of the guidelines recommend cystoscopy with HD and biopsy as a diagnostic prerequisite. Various different techniques have been described for cystoscopy with HD. General or epidural anesthesia is more commonly preferred and advocated while assessing endoscopic alterations in patients suspected of having IC/BPS. Cystoscopy with HD and biopsy enables more objective exclusion of confusable diseases. It also provides the basis of the European Society for the Study of Interstitial Cystitis classification. Patients with IC/BPS who demonstrate positive cystoscopic (glomerulations and/or Hunner lesion) and histologic findings have a more severe symptomatology and may benefit from lesion-targeted endoscopic treatments. Clinical phenotyping has been implemented for IC/BPS and may be used for individualized assessment and treatment.

    Keywords: Bladder pain, cystoscopy, hydrodistension, biopsy, phenotyping

    Introduction

    Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disorder of unknown etiology and is one of the most debilitating conditions in urologic practice. It is characterized by pain, pressure or discomfort perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than six weeks’ duration, in the absence of any identifiable cause such as infection (1,2). IC/BPS can be recognized by the presence of consistent symptoms and signs. Disorders that may lead to a similar symptomatology should be excluded in order to confirm the diagnosis of IC/BPS (2).

    There are significant variations regarding the evaluation and diagnosis of IC/BPS (3). The role of cystoscopy in the diagnosis and classification of IC/BPS has long been a matter of debate, with some authorities such as the European Society for the Study of Interstitial Cystitis (ESSIC) indicating cystoscopy as a diagnostic prerequisite, whereas some others, such as the American Urological Association (AUA) reserve it for complex cases (4).

    Clinical phenotyping, which categorizes the disorder according to the presence or absence of clinically relevant domains, has been implemented in IC/BPS after its success for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in an effort to optimize diagnosis and treatment (5). The main purpose of phenotype mapping in IC/BPS is to better understand the multifactorial etiology of the disorder and enable multimodal and phenotype-directed targeted therapy (6).

    Herein, we review and discuss the contemporary English literature about cystoscopic evaluation and clinical phenotyping in IC/BPS.

    Indications for cystoscopy with hydrodistension and biopsy in IC/BPS

    Technique of cystoscopy + hydrodistension in IC/BPS

    Cystoscopic findings in IC/BPS

    Classification of ic/bps according to findings at cystoscopy with hydrodistension and biopsies

    Clinical implications and correlations regarding cystoscopy with hydrodistension and biopsy findings in IC/BPS

    Clinical phenotyping in IC/BPS

    References

    1
    Hanno PM, Erickson D, Moldwin R, Faraday MM; American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 2015; 193: 1545-53.
    2
    van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008; 53: 60-7.
    3
    Ueda T, Sant GR, Hanno PM, Yoshimura N. Proceedings of the International Consultation on Interstitial Cystitis. March 28-30, 2003. Kyoto, Japan. Int J Urol 2003; 10(Suppl I-IV): 1-70.
    4
    Ens G, Garrido GL. Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome. Transl Androl Urol 2015; 4: 624-8.
    5
    Samplaski MK, Li J, Shoskes DA. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 2012; 188: 1788-93.
    6
    Kartha GK, Kerr H, Shoskes DA. Clinical phenotyping of urologic pain patients. Curr Opin Urol 2013; 23: 560-4.
    7
    Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988; 140: 203-6.
    8
    Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999; 161: 553-7.
    9
    Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology 2001; 57(Suppl 1): 82-8.
    10
    Engeler DS, Baranowski AP, Dinis-Oliveira P, Elneil S, Hughes J, Messelink EJ, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol 2013; 64: 431-9.
    11
    Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese guideline for diagnosis and treatment of interstitial cystitis. Int J Urol 2009; 16: 4-16.
    12
    Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, Lee MH, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol 2009; 16: 597-615.
    13
    Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, et al. Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol Urodyn 2010; 29: 191-8.
    14
    Turner KJ, Stewart LH. How do you stretch a bladder? A survey of UK practice, a literature review, and a recommendation of a standard approach. Neurourol Urodyn 2005; 24: 74-6.
    15
    Nordling J, Anjum FH, Bade JJ, Bouchelouche K, Bouchelouche P, Cervigni M, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 2004; 45: 662-9.
    16
    Doiron RC, Tolls V, Irvine-Bird K, Kelly KL, Nickel JC. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy. J Urol 2016; 196: 1136-40.
    17
    Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int J Urol 2003; 10: 463-8.
    18
    Aihara K, Hirayama A, Tanaka N, Fujitomo K, Yoshida K, Hirao Y. Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol 2009; 16: 947-52.
    19
    Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention? Neurourol Urodyn 2005; 24: 638-42.
    20
    Lamale LM, Lutgendorf SK, Hoffman AN, Kreder KJ. Symptoms and cystoscopic findings in patients with untreated interstitial cystitis. Urology 2006; 67: 242-5.
    21
    Ueda T, Nakagawa M, Okamura M, Tanoue H, Yoshida H, Yoshimura N. New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system. Int J Urol 2008; 15: 1039-43.
    22
    Hand JR. Interstitial cystitis; report of 223 cases (204 women and 19 men). J Urol 1949; 61: 291-310.
    23
    Walsh A. Interstitial cystitis. In: Harrison JH, Gittes RF, Perlmutter AD. Campbell’s Urology, 4th ed. Philadelphia: W. B. Saunders; 1978. p. 693.
    24
    Jiang YH, Kuo HC. Development of Bladder Glomerulations after Hydrodistension in Patients with Upper Urinary Tract Urolithiasis Suggesting Cross Talk and Bladder Inflammation Occur between Upper and Lower Urinary Tract. Int J Urol 2014; 21: A14; Abstr. PO-07.
    25
    Kuo YC, Kuo HC. Are Glomerulations after Cystoscopic Hydrodistention a Pathognomonic Sign for Interstitial Cystitis? Int J Urol 2014; 21: 15.
    26
    Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998; 160: 1663-7.
    27
    Richter B, Hesse U, Hansen AB, Horn T, Mortensen SO, Nordling J. Bladder pain syndrome/interstitial cystitis in a Danish population: a study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis. BJU Int 2010; 105: 660-7.
    28
    Wyndaele JJ, Van Dyck J, Toussaint N. Cystoscopy and bladder biopsies in patients with bladder pain syndrome carried out following ESSIC guidelines. Scand J Urol Nephrol 2009; 43: 471-5.
    29
    Yazıcı C, Tarcan T, Türkeri L, Ülker Y, Şimşek F. The role of cystoscopy in the evaluation of hematuria in the presence of normal radiological and microbiological work-up. Marmara Medical Journal 2003; 16: 255-60.
    30
    Kerr WS Jr. Interstitial cystitis: treatment by transurethral resection. J Urol 1971; 105: 664-6.
    31
    Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 290-5.
    32
    Rofeim O, Hom D, Freid RM, Moldwing RM. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol 2001; 166: 134-6.
    33
    Payne RA, O’Connor RC, Kressin M, Guralnick ML. Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. Can Urol Assoc J 2009; 3: 473-7.
    34
    Cox M, Klutke JJ, Klutke CG. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner’s ulcer subtype interstitial cystitis. Can J Urol 2009; 16: 4536-40.
    35
    Peters KM, Girdler B, Carrico D, Ibrahim I, Diokno A. Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 665-9.
    36
    Braunstein R, Shapiro E, Kaye J, Moldwin R. The role of cystoscopy in the diagnosis of Hunner’s ulcer disease. J Urol 2008; 180: 1383-6.
    37
    Logadottir Y, Fall M, Kåbjörn-Gustafsson C, Peeker R. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol 2012; 46: 365-70.
    38
    Boudry G, Labat JJ, Riant T, Le Normand L, Manunta A, Bensalah K, et al. Validation of voiding diary for stratification of bladder pain syndrome according to the presence/absence of cystoscopic abnormalities: a two-centre prospective study. BJU Int 2013; 112: 164-8.
    39
    Ahn ST, Jeong HG, Park TY, Kim JW, Park HS, Moon DG, et al. Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women with Interstitial Cystitis/Bladder Pain Syndrome. Int Neurourol J 2018; 22(Suppl 1): 55-61.
    40
    Inoue R, Takahashi S, Sunaoshi K, Ichiara K, Masumori N, Tsukamoto T. Hydrodistention of the bladder in patients with interstitial cystitis clinical efficacy and its association with immunohistochemical findings for bladder tissues. Hinyokika Kiyo 2006; 52: 765-8.
    41
    Grossklaus DJ, Franke JJ. Vesical necrosis after hydrodistension of the urinary bladder in a patient with interstitial cystitis. BJU Int 2000; 86: 140-1.
    42
    Azadzoi KM, Shinde VM, Tarcan T, Kozlowski R, Siroky MB. Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder. J Urol 2003; 169: 1885-91.
    43
    Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome (IC/PBS): a key to classification and potentially improved management. J Urol 2009; 182: 155-60.
    44
    Acar Ö, Tarcan T. Kronik Pelvik Ağrı Sınıflaması ve Mesane Ağrısı Sendromunda Epidemiyoloji, Etyoloji ve Patogenez. Ürolojik Cerrahi Derneği, Güncelleme Serileri, 2015; 4: 7-13.
    45
    Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 2010; 184: 1358-63.
    46
    Cox A, Golda N, Nadeau G, Curtis Nickel J, Carr L, Corcos J, Teichman J. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J 2016; 10 :E136-E155.
    2024 ©️ Galenos Publishing House